HK1201826A1 - Benzamide derivatives as modulators of the follicle stimulating hormone - Google Patents
Benzamide derivatives as modulators of the follicle stimulating hormoneInfo
- Publication number
- HK1201826A1 HK1201826A1 HK15102218.5A HK15102218A HK1201826A1 HK 1201826 A1 HK1201826 A1 HK 1201826A1 HK 15102218 A HK15102218 A HK 15102218A HK 1201826 A1 HK1201826 A1 HK 1201826A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- modulators
- stimulating hormone
- follicle stimulating
- benzamide derivatives
- benzamide
- Prior art date
Links
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 title 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 title 1
- 150000003936 benzamides Chemical class 0.000 title 1
- 229940028334 follicle stimulating hormone Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
- A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/02—Instruments or methods for reproduction or fertilisation for artificial insemination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Surgery (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261585077P | 2012-01-10 | 2012-01-10 | |
| PCT/US2013/020802 WO2013106409A1 (en) | 2012-01-10 | 2013-01-09 | Benzamide derivatives as modulators of the follicle stimulating hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201826A1 true HK1201826A1 (en) | 2015-09-11 |
Family
ID=47595088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102218.5A HK1201826A1 (en) | 2012-01-10 | 2015-03-04 | Benzamide derivatives as modulators of the follicle stimulating hormone |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9409897B2 (ja) |
| EP (2) | EP3327017B1 (ja) |
| JP (1) | JP6219844B2 (ja) |
| CN (1) | CN104080784B (ja) |
| AU (1) | AU2013208082B2 (ja) |
| CA (1) | CA2860808A1 (ja) |
| ES (2) | ES2738600T3 (ja) |
| HK (1) | HK1201826A1 (ja) |
| IL (1) | IL233602A (ja) |
| WO (1) | WO2013106409A1 (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2734517B1 (en) | 2011-07-18 | 2017-08-30 | Merck Patent GmbH | Benzamides |
| WO2013106409A1 (en) * | 2012-01-10 | 2013-07-18 | Merck Patent Gmbh | Benzamide derivatives as modulators of the follicle stimulating hormone |
| WO2015196335A1 (en) | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Pyrazole compounds as modulators of fshr and uses thereof |
| CN106177912B (zh) * | 2016-07-18 | 2019-06-18 | 暨南大学 | Ctrp3蛋白的应用 |
| US11856264B2 (en) | 2016-11-15 | 2023-12-26 | Google Llc | Systems and methods for reducing download requirements |
| US10513515B2 (en) | 2017-08-25 | 2019-12-24 | Biotheryx, Inc. | Ether compounds and uses thereof |
| US11236103B2 (en) | 2018-07-27 | 2022-02-01 | Biotheryx, Inc. | Bifunctional compounds |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| WO2021222150A2 (en) | 2020-04-28 | 2021-11-04 | Anwita Biosciences, Inc. | Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications |
| EP4367112A1 (en) | 2021-07-09 | 2024-05-15 | Plexium, Inc. | Aryl compounds and pharmaceutical compositions that modulate ikzf2 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2339018A1 (en) * | 1998-08-07 | 2000-02-17 | Applied Research Systems Ars Holding N.V. | Fsh mimetics for the treatment of infertility |
| CA2397575A1 (en) * | 2000-01-13 | 2001-07-19 | Tularik Inc. | Antibacterial agents |
| JP2004505051A (ja) * | 2000-07-27 | 2004-02-19 | スミスクライン ビーチャム コーポレーション | 卵胞刺激ホルモン活性のアゴニスト |
| AU2006296004B2 (en) * | 2005-09-27 | 2011-11-17 | Shionogi & Co., Ltd. | Sulfonamide derivative having PGD2 receptor antagonistic activity |
| GB0705656D0 (en) | 2007-03-23 | 2007-05-02 | Addex Pharmaceuticals Sa | Novel compounds E1 |
| PE20091576A1 (es) * | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
| TWI461426B (zh) | 2009-05-27 | 2014-11-21 | Merck Sharp & Dohme | （二氫）咪唑並異〔５，１－ａ〕喹啉類 |
| WO2011014681A1 (en) * | 2009-07-30 | 2011-02-03 | Takeda Pharmaceutical Company Limited | Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS |
| EP2734517B1 (en) * | 2011-07-18 | 2017-08-30 | Merck Patent GmbH | Benzamides |
| WO2013106409A1 (en) * | 2012-01-10 | 2013-07-18 | Merck Patent Gmbh | Benzamide derivatives as modulators of the follicle stimulating hormone |
-
2013
- 2013-01-09 WO PCT/US2013/020802 patent/WO2013106409A1/en active Application Filing
- 2013-01-09 EP EP17209280.1A patent/EP3327017B1/en active Active
- 2013-01-09 CN CN201380005089.4A patent/CN104080784B/zh not_active Expired - Fee Related
- 2013-01-09 CA CA2860808A patent/CA2860808A1/en not_active Abandoned
- 2013-01-09 EP EP13700819.9A patent/EP2802575B1/en not_active Not-in-force
- 2013-01-09 ES ES17209280T patent/ES2738600T3/es active Active
- 2013-01-09 JP JP2014552261A patent/JP6219844B2/ja not_active Expired - Fee Related
- 2013-01-09 US US14/364,193 patent/US9409897B2/en active Active
- 2013-01-09 AU AU2013208082A patent/AU2013208082B2/en not_active Ceased
- 2013-01-09 ES ES13700819.9T patent/ES2663972T3/es active Active
-
2014
- 2014-07-10 IL IL233602A patent/IL233602A/en active IP Right Grant
-
2015
- 2015-03-04 HK HK15102218.5A patent/HK1201826A1/xx not_active IP Right Cessation
- 2015-11-18 US US14/944,324 patent/US20160137632A1/en not_active Abandoned
-
2017
- 2017-04-26 US US15/497,612 patent/US10183935B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP6219844B2 (ja) | 2017-10-25 |
| WO2013106409A1 (en) | 2013-07-18 |
| EP3327017B1 (en) | 2019-04-24 |
| CA2860808A1 (en) | 2013-07-18 |
| US20160137632A1 (en) | 2016-05-19 |
| CN104080784A (zh) | 2014-10-01 |
| EP2802575B1 (en) | 2017-12-27 |
| EP2802575A1 (en) | 2014-11-19 |
| IL233602A (en) | 2016-04-21 |
| EP3327017A1 (en) | 2018-05-30 |
| ES2738600T3 (es) | 2020-01-24 |
| US20150011562A1 (en) | 2015-01-08 |
| US9409897B2 (en) | 2016-08-09 |
| IL233602A0 (en) | 2014-08-31 |
| JP2015503615A (ja) | 2015-02-02 |
| US20170226096A1 (en) | 2017-08-10 |
| AU2013208082B2 (en) | 2017-07-20 |
| CN104080784B (zh) | 2017-07-18 |
| ES2663972T3 (es) | 2018-04-17 |
| AU2013208082A1 (en) | 2014-07-03 |
| US10183935B2 (en) | 2019-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181296T1 (hr) | Novi spojevi za suzbijanje člankonožaca | |
| IL287516A (en) | Medicinal uses of empagliflozin | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| IL255045A0 (en) | A crystal of flumioxazin | |
| HK1201826A1 (en) | Benzamide derivatives as modulators of the follicle stimulating hormone | |
| HK1210172A1 (en) | Crystal of dispiropyrrolidine derivative | |
| HK1213818A1 (zh) | 依帕列淨的治療用途 | |
| PL2981271T3 (pl) | Zastosowania terapeutyczne empagliflozyny | |
| EP2827937A4 (en) | ANTISEPTIC APPLICATOR | |
| ZA201406082B (en) | Use of ccr3-inhibitors | |
| EP2953605A4 (en) | USE OF A COSMETIC COMPOSITION | |
| HK1211480A1 (en) | External preparation for skin | |
| PL2812013T3 (pl) | Formulacja do leczenia ibs | |
| EP2841145A4 (en) | ANTISEPTIC APPLICATOR | |
| HK1221643A1 (zh) | 皮膚外用劑 | |
| EP2925363A4 (en) | METHOD FOR MODULATING FOLLICLE-STIMULATING HORMONACTIVITY | |
| EP2895504A4 (en) | TRPV3 AGONISTS FOR THE TREATMENT OF SKIN DISEASES | |
| EP3054996A4 (en) | High purity therapeutic bone agents | |
| IL236079A0 (en) | Flumioxazin crystal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220114 |